# Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer

> **NCT02423148** · NA · WITHDRAWN · sponsor: **Dana-Farber Cancer Institute**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Indocyanine green (ICG)
- **DEVICE:** FluoSCOPE

## Key facts

- **NCT ID:** NCT02423148
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-11-03
- **Final completion:** 2016-11-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Co-investigator left facility. Decided not to enroll patients therefore.
- **Last updated:** 2018-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02423148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02423148, "Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02423148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*